New drug approval process on the anvil
NITI Aayog proposes a streamlined evaluation process in the pharma and medical research sector in bid to boost innovation
New Delhi: The NITI Aayog has proposed sweeping changes to the approvals process in the pharmaceutical and medical research sector in order to encourage innovation. NITI Aayog, with the Prime Minister’s Office in loop, has asked several ministries involved in the overall process of product (drug or vaccine) development, to streamline, update and simplify the process.
Login to enjoy exclusive benefits!
- Unlocked premium articles
- Personalized news
- Market Watchlist
- Insightful Newsletters & more